These cancer patients write their own story
They hurt. They weep. They fly. They soar above the thunderheads. They plunge back to earth. They hold fast to their lovers and their children. They bruise. They burn. They heal. Cancer is not a...
They hurt. They weep. They fly. They soar above the thunderheads. They plunge back to earth. They hold fast to their lovers and their children. They bruise. They burn. They heal. Cancer is not a...
Portland rockers rally around musician’s fight with leukemia. Boxes. Every room was filled with cardboard boxes – a rectangular riot of books, records, photos, tools, kitchen stuff and music...
June 4 is National Cancer Survivors Day. To honor this occasion, we’re sharing the stories of six survivors who inspire us. Some are public figures who are famous the world over. Others are people...
Drugs known as PARP-1 inhibitors have emerged as an important but limited treatment option for certain cancers. Now scientists at Oregon Health & Science University have uncovered a new class of...
His life was blasted apart by a rare but vicious type of cancer. Could an experimental treatment help? When Derek Fadness woke up, the room was dark and his face was swaddled in bandages. He could...
Acute myeloid leukemia, or AML, is the most common acute blood cancer in adults — and one of the most difficult to treat. Scientists at Oregon Health & Science University have discovered a...
Targeted cancer therapies can be stunningly effective at blocking specific, cancer-driving signals. But all too often, tumors develop resistance by switching to alternative signaling pathways to...
Targeted cancer therapies work by blocking specific, cancer-driving mutations. But in a new laboratory study, researchers show that cancers driven by several different mutations can all be stopped by...
Researchers have verified a much-needed new target for treating cancers that often become resistant to existing therapies and become deadly. In an early-phase clinical trial, the researchers tested...
This week, the OHSU Knight Cancer Institute opened a new, 13,000-square-foot space devoted to serving patients taking part in early-phase clinical trials. The unit completes the build-out of the...
Cancer researchers have discovered a potential way to make targeted therapy drugs more effective and longer lasting for people with acute myeloid leukemia, or AML. The scientists showed how it is...